According to a new report, published by KBV research, The Global RNA Analysis Market size is expected to reach $28 billion by 2028, rising at a market growth of 15.6% CAGR during the forecast period.
The Instruments segment is showcasing a CAGR of 15.9% during (2022 - 2028). It is due to the increasing demand for high-quality reagents and kits as well as the frequent use of reagents and media in transcriptome investigations. Strong performance and unrivaled efficiency are made possible by high-quality reagents and kits, which also help to produce sequencing results that are trustworthy, reproducible, and affordable.
The Real Time-PCR (qPCR) Technology segment acquired maximum revenue share in the Global RNA Analysis Market by Technology in 2021 thereby, achieving a market value of $11.7 billion by 2028. The large-scale use of PCR for COVID-19 diagnostics around the nation was linked for the high share. The most effective way for examining a large variety of samples containing a relatively modest number of transcripts is the use of extremely sensitive and quantitative qPCR technology.
The Government Institutes & Academic Centers segment has shown the growth rate of 15% during the (2022 - 2028). It is due to the increasing adoption of high throughput technology for the efficient process of RNA analysis by government agencies and academic institutions. The demand in the pharmaceutical and biotechnology industries is being driven by the growing applications of RNA Analysis technologies in drug discovery.
The Infectious Diseases & Pathogenesis segment is generating highest revenue share the Global RNA Analysis Market by Application in 2021 thereby, achieving a market value of $6.5 billion by 2028. It is because scRNA-sequencing is being used more frequently to provide details about cell types that are susceptible to infection. The treatment of individuals, as well as the study of infectious illnesses and their causes, are being revolutionized by next-generation sequencing.
The North America market dominated the Global RNA Analysis Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $11.4 billion by 2028. The Europe market is exhibiting a CAGR of 15.1% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 16.1% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/rna-analysis-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.
By Product
By Technology
By End-use
By Application
By Geography
Companies Profiled
Unique Offerings 
